Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Viewpoints

Nov 1, 2017/Magazine

Ask Questions. Remember Wellness.

An APTA Virtual Conference Experience Made Attendance Possible

Dec 14, 2020/Perspective

My favorite part of the conference was getting to meet other passionate students who are excited about this profession and have so many interests.

How Do I Get Involved?

Apr 2, 2020/Perspective

While I know that I have only scratched the surface of what it means to be involved in APTA, I do have some advice for students who may be in that same boat.

Study: Excessive Sitting Time Is a Global Problem

Jul 6, 2022/Review

Researchers say sedentary lifestyles are increasing death and CVD rates worldwide — and that lower-income countries may be at greater risk.

States Affected by Helene Eligible for Temporary Regulatory Waivers

Oct 8, 2024/News

CMS is offering flexibility in some regulatory requirements as well as advance or accelerated payment to affected states.

The Good Stuff: Members and the Profession in the Media, January 2021

Jan 19, 2021/Roundup

Individual PTs and PTAs are transforming health care and society every day.

Advocacy: Easy, Accessible, Important

Feb 25, 2018/Perspective

Maybe advocacy sounds boring, unappealing, or unimportant to you. To that I say, hogwash!

From PTJ: Attention to Exercise Attitudes May Help Cancer Survivors With CRF

Mar 31, 2023/Review

Authors believe that accounting for patient self-efficacy could make a difference in exercise among patients with cancer-related fatigue.

The Good Stuff: Members and the Profession in the Media, June 2018

Jun 13, 2018/News

"The Good Stuff," is an occasional series that highlights recent media coverage of physical therapy and APTA members, with an emphasis on good news and stories of how individual PTs and PTAs are transforming health care and society every day.

Research Review: Manual Therapy for CTS as Effective as Surgery

Nov 18, 2020/Review

Manual therapy with a focus on nociceptive pain mechanisms should be a first-line treatment for carpal tunnel syndrome, say researchers.